bnt211
biontech
['bnt-211', 'biontech']
updated results at #esmo22 from -group's phase 1/2 trial of bnt-211 build the case for its boosted car-t therapy approach for solid tumours #oncology 
https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate